CA Stock MarketDetailed Quotes

PharmaTher Holdings Ltd (PHRM)

Watchlist
  • 0.075
  • 0.0000.00%
15min DelayMarket Closed May 7 15:59 ET
6.83MMarket Cap-3.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PharmaTher Holdings Ltd (PHRM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Nov 30, 2025
(Q1)Aug 31, 2025
(FY)May 31, 2025
(Q4)May 31, 2025
(Q3)Feb 28, 2025
(Q2)Nov 30, 2024
(Q1)Aug 31, 2024
(FY)May 31, 2024
(Q4)May 31, 2024
(Q3)Feb 29, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-39.06%211.03K
1.90%335.38K
-49.18%1.57M
35.37%535.88K
-15.23%357.46K
-62.17%346.29K
-75.69%329.14K
-23.12%3.09M
-65.08%395.86K
-49.13%421.66K
Selling and administrative expenses
-20.32%183.64K
-28.81%169.67K
4.17%942.08K
42.80%277.72K
-8.63%195.56K
6.31%230.47K
-14.59%238.33K
-3.97%904.37K
-30.13%194.48K
-7.34%214.03K
-General and administrative expense
-20.32%183.64K
-28.81%169.67K
4.17%942.08K
42.80%277.72K
-8.63%195.56K
6.31%230.47K
-14.59%238.33K
-3.97%904.37K
-30.13%194.48K
-7.34%214.03K
Research and development costs
-81.43%17.56K
81.17%150.8K
-72.82%581.56K
29.99%249.3K
-22.82%154.48K
-86.12%94.55K
-92.20%83.23K
-29.10%2.14M
-77.45%191.79K
-65.78%200.17K
Other operating expenses
-53.76%9.84K
96.94%14.92K
6.04%45.13K
-7.47%8.87K
-0.62%7.41K
20.80%21.28K
-4.16%7.58K
-22.54%42.56K
102.83%9.59K
-42.69%7.46K
Operating profit
39.06%-211.03K
-1.90%-335.38K
49.18%-1.57M
-35.37%-535.88K
15.23%-357.46K
62.17%-346.29K
75.69%-329.14K
23.12%-3.09M
65.08%-395.86K
49.13%-421.66K
Net non-operating interest income (expenses)
-99.97%6
-99.98%5
-67.93%59.87K
-82.95%4.99K
-71.21%11.1K
-62.76%18.84K
-63.48%24.95K
-9.73%186.7K
-38.76%29.29K
-48.52%38.54K
Non-operating interest income
-99.97%6
-99.98%5
-67.93%59.87K
-82.95%4.99K
-71.21%11.1K
-62.76%18.84K
-63.48%24.95K
-9.73%186.7K
-38.76%29.29K
-48.52%38.54K
Other net income (expenses)
6.92%-37.43K
-36.66%-103.82K
92.01%-17.21K
1,943.91%122.1K
-213.59%-23.12K
79.27%-40.22K
-59.24%-75.97K
91.74%-215.4K
101.18%5.97K
20.36K
Gain on sale of security
0.00%-33.33K
-50.00%-100K
120.00%33.33K
--133.33K
----
81.48%-33.33K
-400.02%-66.67K
93.67%-166.67K
--0
--26.67K
Income before tax
32.42%-248.46K
-15.53%-439.19K
51.01%-1.53M
-13.36%-408.79K
-1.85%-369.48K
65.28%-367.67K
71.48%-380.16K
51.45%-3.12M
77.38%-360.6K
51.89%-362.76K
Income tax
Earnings from equity interest net of tax
Net income
32.42%-248.46K
-15.53%-439.19K
51.01%-1.53M
-13.36%-408.79K
-1.85%-369.48K
65.28%-367.67K
71.48%-380.16K
51.45%-3.12M
77.38%-360.6K
51.89%-362.76K
Net income continuous operations
32.42%-248.46K
-15.53%-439.19K
51.01%-1.53M
-13.36%-408.79K
-1.85%-369.48K
65.28%-367.67K
71.48%-380.16K
51.45%-3.12M
77.38%-360.6K
51.89%-362.76K
Noncontrolling interests
Net income attributable to the company
32.42%-248.46K
-15.53%-439.19K
51.01%-1.53M
-13.36%-408.79K
-1.85%-369.48K
65.28%-367.67K
71.48%-380.16K
51.45%-3.12M
77.38%-360.6K
51.89%-362.76K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
32.42%-248.46K
-15.53%-439.19K
51.01%-1.53M
-13.36%-408.79K
-1.85%-369.48K
65.28%-367.67K
71.48%-380.16K
51.45%-3.12M
77.38%-360.6K
51.89%-362.76K
Diluted earnings per share
0
0
50.00%-0.02
0.00%-0.01
0
0
0
42.86%-0.04
50.00%-0.01
0
Basic earnings per share
0
0
50.00%-0.02
0.00%-0.01
0
0
0
42.86%-0.04
50.00%-0.01
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Nov 30, 2025(Q1)Aug 31, 2025(FY)May 31, 2025(Q4)May 31, 2025(Q3)Feb 28, 2025(Q2)Nov 30, 2024(Q1)Aug 31, 2024(FY)May 31, 2024(Q4)May 31, 2024(Q3)Feb 29, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -39.06%211.03K1.90%335.38K-49.18%1.57M35.37%535.88K-15.23%357.46K-62.17%346.29K-75.69%329.14K-23.12%3.09M-65.08%395.86K-49.13%421.66K
Selling and administrative expenses -20.32%183.64K-28.81%169.67K4.17%942.08K42.80%277.72K-8.63%195.56K6.31%230.47K-14.59%238.33K-3.97%904.37K-30.13%194.48K-7.34%214.03K
-General and administrative expense -20.32%183.64K-28.81%169.67K4.17%942.08K42.80%277.72K-8.63%195.56K6.31%230.47K-14.59%238.33K-3.97%904.37K-30.13%194.48K-7.34%214.03K
Research and development costs -81.43%17.56K81.17%150.8K-72.82%581.56K29.99%249.3K-22.82%154.48K-86.12%94.55K-92.20%83.23K-29.10%2.14M-77.45%191.79K-65.78%200.17K
Other operating expenses -53.76%9.84K96.94%14.92K6.04%45.13K-7.47%8.87K-0.62%7.41K20.80%21.28K-4.16%7.58K-22.54%42.56K102.83%9.59K-42.69%7.46K
Operating profit 39.06%-211.03K-1.90%-335.38K49.18%-1.57M-35.37%-535.88K15.23%-357.46K62.17%-346.29K75.69%-329.14K23.12%-3.09M65.08%-395.86K49.13%-421.66K
Net non-operating interest income (expenses) -99.97%6-99.98%5-67.93%59.87K-82.95%4.99K-71.21%11.1K-62.76%18.84K-63.48%24.95K-9.73%186.7K-38.76%29.29K-48.52%38.54K
Non-operating interest income -99.97%6-99.98%5-67.93%59.87K-82.95%4.99K-71.21%11.1K-62.76%18.84K-63.48%24.95K-9.73%186.7K-38.76%29.29K-48.52%38.54K
Other net income (expenses) 6.92%-37.43K-36.66%-103.82K92.01%-17.21K1,943.91%122.1K-213.59%-23.12K79.27%-40.22K-59.24%-75.97K91.74%-215.4K101.18%5.97K20.36K
Gain on sale of security 0.00%-33.33K-50.00%-100K120.00%33.33K--133.33K----81.48%-33.33K-400.02%-66.67K93.67%-166.67K--0--26.67K
Income before tax 32.42%-248.46K-15.53%-439.19K51.01%-1.53M-13.36%-408.79K-1.85%-369.48K65.28%-367.67K71.48%-380.16K51.45%-3.12M77.38%-360.6K51.89%-362.76K
Income tax
Earnings from equity interest net of tax
Net income 32.42%-248.46K-15.53%-439.19K51.01%-1.53M-13.36%-408.79K-1.85%-369.48K65.28%-367.67K71.48%-380.16K51.45%-3.12M77.38%-360.6K51.89%-362.76K
Net income continuous operations 32.42%-248.46K-15.53%-439.19K51.01%-1.53M-13.36%-408.79K-1.85%-369.48K65.28%-367.67K71.48%-380.16K51.45%-3.12M77.38%-360.6K51.89%-362.76K
Noncontrolling interests
Net income attributable to the company 32.42%-248.46K-15.53%-439.19K51.01%-1.53M-13.36%-408.79K-1.85%-369.48K65.28%-367.67K71.48%-380.16K51.45%-3.12M77.38%-360.6K51.89%-362.76K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 32.42%-248.46K-15.53%-439.19K51.01%-1.53M-13.36%-408.79K-1.85%-369.48K65.28%-367.67K71.48%-380.16K51.45%-3.12M77.38%-360.6K51.89%-362.76K
Diluted earnings per share 0050.00%-0.020.00%-0.0100042.86%-0.0450.00%-0.010
Basic earnings per share 0050.00%-0.020.00%-0.0100042.86%-0.0450.00%-0.010
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.43%
4
CNOOC
00883
-0.83%
5
PETROCHINA
00857
-1.67%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +62.04%
Sample Name
Sample Code
 +51.30%
Sample Name
Sample Code
 +46.36%
4
Loongson Technology Corporation
688047
+36.75%
5
Business-intelligence Of Oriental Nations Corporation
300166
+31.45%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -